EIN: 81-3250208 · Boston, MA
The Institute for Protein Innovation, founded by Timothy A. Springer, Ph.D., in 2017, addresses the limitations of for-profit companies in biological research. By generating synthetic, recombinant antibodies, IPI supports exploratory protein research and collaborates with prestigious institutions.
Since its inception, IPI has successfully licensed its first antibody in 2020, enhancing the quality and availability of antibodies for scientific research. This work is crucial in addressing the reproducibility crisis in antibody-based research.
Your donation to IPI supports the advancement of high-quality, well-characterized antibodies essential for scientific research and therapeutic development.
Join the mission to revolutionize protein research by donating cryptocurrency or cash to the Institute for Protein Innovation. Your contribution can lead to breakthroughs in medicine and biology!
Do you represent Institute for Protein Innovation? Sign up and claim this page to customize it and gain access to our dashboard. Learn More.